Skip to main content
TipRanks
Go Ultimate75% OFF

Rapid Therapeutic Science Laboratories (RTSL) Income Statement

28 Followers

Rapid Therapeutic Science Laboratories Income Statement

Last quarter (Q2 2023), Rapid Therapeutic Science Laboratories's total revenue was $0.00. In Q2, Rapid Therapeutic Science Laboratories's net income was $46.42K. See Rapid Therapeutic Science Laboratories’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 22Dec 21Mar 20Mar 18
$ 0.00$ 534.00$ 9.14K$ 0.00
$ 0.00$ 334.00$ 1.98K$ 0.00
$ 1.26M$ 2.17M$ 169.69K$ 152.07K
Depreciation and Amortization$ 23.97K$ 55.86K$ 37.50K$ 16.39K
$ -1.24M$ -2.11M$ -132.19K$ -135.68K
$ -1.26M$ -2.17M$ -169.69K$ -2.52M
$ -531.39K$ -697.59K$ 1.38K$ -2.37M
$ -1.79M$ -2.87M$ -348.84K$ -2.55M
$ -1.69M$ -4.20M$ -348.84K$ -2.55M
Per Share Metrics
Basic EPS$ -0.22$ -0.55$ -7.24$ -25.88
Diluted EPS$ -0.22$ -0.55$ -7.24$ -25.88
Weighted Average Shares Outstanding7.75M7.63M48.16K98.64K
Weighted Average Shares Outstanding (Diluted)7.75M7.63M48.16K98.64K

Currency in USD

Rapid Therapeutic Science Laboratories Earnings and Revenue History

-5M-2.5M02.5M-900000 %-600000 %-300000 %0 %EarningsProfit Margin2017201920212022RevenueEarningsProfit Margin